期刊
PLOS ONE
卷 8, 期 1, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0053064
关键词
-
资金
- European Union Marie Curie Actions [MEST-CT-2005-020311]
- Medical Research Council [G0800148]
- European Molecular Biology Organization [ALTF 1177-2007]
- Wellcome Trust (UK) [092686/Z/10/Z]
- MRC [G0800148, MR/J006874/1] Funding Source: UKRI
- Medical Research Council [G0800148] Funding Source: researchfish
- Wellcome Trust [092686/Z/10/Z] Funding Source: Wellcome Trust
Intracellular replication of Salmonella enterica requires effector proteins translocated across the Salmonella-containing vacuolar membrane by Salmonella pathogenicity island-2 (SPI-2) encoded type III secretion system (T3SS). The SPI-2 T3SS effector SseL is a deubiquitinase that contributes to virulence in mice. Previous work has produced conflicting evidence as to the involvement of SseL in interference with the NF-kappa B pathway. To attempt to clarify these discrepancies, we compared mRNA levels in mouse primary bone marrow-derived macrophages infected with wild-type or sseL mutant strains using a genome-wide microarray. There was no detectable effect of loss of SseL on mRNA levels corresponding to any known NF-kappa B-regulated gene. In addition, there was no effect of SseL on (i) the activation or levels of both the canonical inhibitor of the NF-kappa B pathway (I kappa B alpha and phospho-I kappa B alpha), and the non-canonical NF-kappa B precursor p100/p52, (ii) the translocation of the NF-kappa B transcription factor p65 to the nucleus of infected macrophages and (iii) pro-inflammatory cytokines secretion. Furthermore, ectopic expression of SseL did not affect NF-kappa B activation in reporter cell lines. These results fail to support a role for SseL in the down-regulation of the host immune response and in particular the NF-kappa B pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据